【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by disease type
• Rheumatoid arthritis
• Osteoarthritis
• Osteoporosis
• Psoriatic arthritis
• Ankylosing spondylitis
• Fibromyalgia
PART 08: Global rheumatoid arthritis drugs market
• Market overview
PART 09: Global osteoarthritis drugs market
• Market overview
PART 10: Global osteoporosis drugs market
• Market overview
PART 11: Global ankylosing spondylitis drugs market
• Market overview
PART 12: Global psoriatic arthritis drugs market
• Market overview
PART 13: Global fibromyalgia drugs market
• Market overview
PART 14: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 15: Market segmentation by route of administration
• Parenteral
• Topical
• Oral
PART 16: Geographical segmentation
• Global musculoskeletal disorder therapeutics market by geography 2015-2020
• Musculoskeletal disorders therapeutics market in Americas
• Musculoskeletal disorders therapeutics market in EMEA
• Musculoskeletal disorders therapeutics market in APAC
PART 17: Market drivers
• High growth potential of mAbs
• Unmet needs of therapeutics
• Tentative approval of advanced drugs
• Technological advancements in medical imaging
• Combination therapies
PART 18: Impact of drivers
PART 19: Market challenges
• Non-adherence to treatment regimen
• Growing preference toward surgeries
• Multiple patent expiries
PART 20: Impact of drivers and challenges
PART 21: Market trends
• Focus on regenerative medicines
• Ongoing active clinical trials for biosimilars
• Growing focus toward abuse-resistant novel drugs
PART 22: Vendor landscape
• Competitive scenario
PART 23: Key vendor analysis
• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
• Other prominent vendors
PART 24: Appendix
• List of abbreviations
PART 25: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments for musculoskeletal disorder therapeutics
Exhibit 03: Impact of biologics on various sectors
Exhibit 04: Pipeline portfolio: Global rheumatoid arthritis drugs market
Exhibit 05: Pipeline portfolio: Global osteoarthritis drugs market
Exhibit 06: Pipeline portfolio: Global osteoporosis drugs market
Exhibit 07: Pipeline portfolio: Global psoriatic arthritis drugs market
Exhibit 08: Pipeline portfolio: Global fibromyalgia drugs market
Exhibit 09: Pipeline portfolio: Global ankylosing spondylitis drugs market
Exhibit 10: Global musculoskeletal disorder therapeutics market 2015-2020 ($ billions)
Exhibit 11: Patient assistance programs offered by companies
Exhibit 12: CAM therapies for rheumatoid arthritis
Exhibit 13: Five forces analysis
Exhibit 14: Segmentation of global musculoskeletal disorder therapeutics market
Exhibit 15: Segmentation of global musculoskeletal disorder therapeutics market by revenue 2015
Exhibit 16: Opportunities in rheumatoid arthritis drugs industry
Exhibit 17: Global rheumatoid arthritis drugs market 2015-2020 ($ billions)
Exhibit 18: Unmet medical needs with current osteoarthritis treatments
Exhibit 19: Global osteoarthritis drugs market 2015-2020 ($ billions)
Exhibit 20: Global osteoporosis drugs market 2015-2020 ($ billions)
Exhibit 21: Global ankylosing spondylitis drugs market 2015-2020 ($ billions)
Exhibit 22: Global psoriatic arthritis drugs market 2015-2020 ($ billions)
Exhibit 23: Global fibromyalgia drugs market 2015-2020 ($ billions)
Exhibit 24: Segmentation of global musculoskeletal disorder therapeutics market by type of molecules 2015
Exhibit 25: Segmentation of global musculoskeletal disorder therapeutics market by ROA 2015
Exhibit 26: Global musculoskeletal disorder therapeutics market by geography 2015-2020
Exhibit 27: Global musculoskeletal disorder therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 28: Global share of musculoskeletal disorders therapeutics market by geography 2015
Exhibit 29: Global musculoskeletal disorder therapeutics market: Country analysis based on revenue and growth rate
Exhibit 30: Musculoskeletal disorders therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 31: Musculoskeletal disorders therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 32: Musculoskeletal disorders therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 33: Few of the late-stage mAbs under development for various musculoskeletal disorders
Exhibit 34: Impact of drivers
Exhibit 35: Approval and patent expiries of top selling biologics
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Key vendors ranking 2015
Exhibit 38: Geographical presence of key vendors
Exhibit 39: Competitive scenario of global musculoskeletal disorder therapeutics market vendors 2015-2020
Exhibit 40: AbbVie: YoY revenue and growth rate of Humira 2013-2015 ($ billions)
Exhibit 41: AbbVie: Geographical segmentation of Humira 2015
Exhibit 42: AbbVie: Metrics analysis
Exhibit 43: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 44: Johnson & Johnson: YoY revenue and growth rate of Remicade 2013-2015 ($ billions)
Exhibit 45: Johnson & Johnson: YoY revenue and growth rate of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 46: Johnson & Johnson: YoY revenue and growth rate of Stelara 2013-2015 ($ billions)
Exhibit 47: Johnson & Johnson: Metrics analysis
Exhibit 48: Amgen: YoY revenue and growth rate of Enbrel (US and Canada) 2013-2015 ($ billions)
Exhibit 49: Amgen: YoY revenue and growth rate of Prolia 2013-2015 ($ billions)
Exhibit 50: Amgen: Geographical segmentation of Prolia 2015
Exhibit 51: Amgen: Metrics analysis
Exhibit 52: Key products in musculoskeletal disorders market with 2015 revenues
Exhibit 53: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
Exhibit 54: Pfizer: YoY revenue and growth rate of Enbrel (outside US and Canada) 2013-2015 ($ billions)
Exhibit 55: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
Exhibit 56: Pfizer: YoY revenue and growth rate of Xeljanz 2013-2015 ($ millions)
Exhibit 57: Pfizer: Metrics analysis
Exhibit 58: F. Hoffmann-La Roche: YoY revenue and growth rate of MabThera/Rituxan 2013-2015 ($ billions)
Exhibit 59: F. Hoffmann-La Roche: Geographical segmentation of MabThera/Rituxan by revenue 2015
Exhibit 60: F. Hoffmann-La Roche: YoY revenue and growth rate of Actemra/RoActemra 2013-2015 ($ billions)
Exhibit 61: F. Hoffmann-La Roche: Geographical segmentation of Actemra/RoActemra by revenue 2015
Exhibit 62: F. Hoffmann-La Roche: Metrics analysis
Exhibit 63: Eli Lilly: YoY revenue and growth rate of Cymbalta 2013-2015 ($ billions)
Exhibit 64: Eli Lilly: YoY revenue and growth rate of Evista 2013-2015 ($ billions)
Exhibit 65: Eli Lilly: Geographical segmentation of Evista 2015
Exhibit 66: Eli Lilly: YoY revenue and growth rate of Forteo 2013-2015 ($ billions)
Exhibit 67: Eli Lilly: Geographical segmentation of Forteo 2015
Exhibit 68: Eli Lilly: Metrics analysis
【レポート販売概要】
■ タイトル:筋骨格障害治療薬の世界市場:リウマチ性関節炎、骨関節炎、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症■ 英文:Global Musculoskeletal Disorders Therapeutics Market 2016-2020
■ 発行日:2016年8月31日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10170
■ 調査対象地域:グローバル
- ベビー用おむつの世界市場:使い捨ておむつ、トレーニングおむつ、布製おむつ、スイムパンツ、生分解性おむつAbout Baby Diaper Diapers are generally made of synthetic disposable materials or cloth. The global baby diaper market is dominated by disposable diapers, followed by training diapers, cloth diapers, swim pants, and biodegradable diapers. Rise in disposable income and growing concerns about hygiene are responsible for the high growth of global baby diaper market. Technavio's analysts forecast the …
- AMC CPU カードの世界市場2014-2018About AMC CPU Cards AMCs are the printed circuit boards that follow the specifications of PICMG, which is a consortium of over 227 companies that collaboratively develop open specifications for high-performance telecommunications and industrial computing applications. AMC product standards are designed to support AdvancedTCA and MicroTCA systems. AMC modules are the key for building MicroTCA platf …
- 消化管疾患治療薬(一般用医薬品)の世界市場:胃食道逆流症(GERD)、便秘、下痢、吐気、鼓腸About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, v …
- 筆記具の世界市場2015-2019Technavios market research analyst predicts the writing and marking instruments market to grow at a CAGR of around 5% during the forecast period. The rising use of luxury writing instruments as a status symbol is the key driver for the growth of this market. During 2014, the market for luxury writing instruments grew by around 6% in South Korea. This growth was largely due to the growing interest …
- 世界の太陽電池用ペースト市場2015The Global Solar Cell Paste Industry Report 2015 is a professional and in-depth study on the current state of the Solar Cell Paste industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Solar Cell Paste market analysis is provided for the international markets including development trends, competitive lan …
- トークナイゼーションの世界市場予測(~2023年)The growing need to protect cardholders’ data by following PCI DSS guidelines is expected to drive the tokenization marketThe tokenization market size is estimated to grow from USD 983 million in 2018 to USD 2,670 million by 2023, at a Compound Annual Growth Rate (CAGR) of 22.1% during the forecast period. The factors expected to drive the tokenization market are the growing need to protect cardho …
- 芝刈り機の世界市場:製品別(ガソリン、電気、手動、ロボット)、最終用途別(住宅、商業用、政府)、地域別、セグメント予測The global lawn mowers market size is expected to reach USD 38.78 billion by 2025 exhibiting a CAGR of 5.2% from 2019 to 2025, according to a study conducted by Grand View Research, Inc. Rapidly expanding residential construction sector across the globe is spurring the demand for landscaping services, which, in turn, is expected to propel the demand for lawn mowers over the forecast period. In add …
- 自動車ブロックチェーンの世界市場:アプリケーション別(金融、モビリティソリューション、スマートコントラクト、サプライチェーン)、プロバイダー別(アプリケーション&ソリューション、ミドルウェア、インフラストラクチャ&プロトコル)、モビリティ別(パーソナルモビリティ、共有モビリティ、コマーシャルモビリティ)Automotive blockchain can be considered as a continuously expanding list of records (also called as blocks), which are linked together using cryptography. They are used to record and stores data for further processes related to automobile. This includes various processes such as smart contracts, IoT along with other processes involved in car sales, service, warranty claim processing, and other rel …
- 腎盂腎炎(Pyelonephritis):世界の治験レビュー2014年下半期版Pyelonephritis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2014" provides data on the Pyelonephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pyelonephritis. It includes an overview of the trial numbers and their recruitment status as per …
- ヨーロッパのワイン市場:スティルワイン、スパークリングワインTechnavio’s market research analyst predicts the wine market in Europe to witness a decline at a rate of around 0.62% during the forecast period. The falling production of grapes in Europe is the primary driver for the decline of the market. Adverse weather conditions in the region are affecting the production of grapes, which is the major component of wines. During 2012, Europe witnessed a 62% de …
- 事業提携・ライセンシング・投資・M&A動向(四半期別):Q3 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
- Market Opportunity: Call Continuity in Voice over LTE (VoLTE)Fourth generation (4G) data services are in the deployment stage, but is will be a few years until there is ubiquitous LTE coverage. Meanwhile, there are competitive threats emerging against incumbent carriers’ core voice services. This is coming at a time when all bearer services (voice and data) are becoming marginalized due to market expectations, economic conditions, and a coming supply side e …
- ベトナムの半導体市場2016-2020About the Semiconductor Market in Vietnam The semiconductor market in Vietnam is at its nascent stage, as there are only a few active vendors present. However, the market has immense growth potential due to its favorable geographic location. With the South China Sea on one side, the country has opportunities to expand trading activities with nearby Southeast Asian countries. The country shares its …
- ニキビ治療薬の世界市場2016-2020Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the America …
- 女性用コンドームの世界市場2017-2021About Female Condoms A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). Technavio’s analysts forecast the global female condoms market to grow at a CAGR of 9.02% during the period 2017-2021. [Covered in this report] The report covers the pres …